Patel Naimish
SEC insider (Form 3/4/5 filer). CIK 0002021679. Director at AgomAb Therapeutics NV (AGMB) and 1 other issuer. 16 reported Form 4/5 transactions since Sep 2024; latest on Sep 11, 2026. Located in ANTWERPEN.
Companies Patel Naimish has filed insider reports for
- AgomAb Therapeutics NV (AGMB): Director
- CRISPR Therapeutics AG (CRSP): Officer, Chief Medical Officer
Patel Naimish
CIK: 0002021679
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Sep 11, 2026AGMB
AgomAb Therapeutics NV
AwardDirectStock Option (Right to Buy)
56.3K shares- - May 29, 2026CRSP
CRISPR Therapeutics AG
AwardDirectRestricted Stock Units
22K shares- - May 29, 2026CRSP
CRISPR Therapeutics AG
SaleDirect3.8K shares at avg. $55.62$211K - May 28, 2026CRSP
CRISPR Therapeutics AG
ExerciseDirect10K shares- - Mar 20, 2026CRSP
CRISPR Therapeutics AG
AwardDirectStock Option (Right to Buy)
38.5K shares- - Mar 20, 2026CRSP
CRISPR Therapeutics AG
AwardDirectRestricted Stock Units
30K shares- - Mar 16, 2026CRSP
CRISPR Therapeutics AG
SaleDirect3.2K shares at avg. $48.26$152K - Mar 14, 2026CRSP
CRISPR Therapeutics AG
ExerciseDirect8.1K shares- - Oct 3, 2025CRSP
CRISPR Therapeutics AG
AwardDirectStock Option (Right to Buy)
16.5K shares- - May 30, 2025CRSP
CRISPR Therapeutics AG
AwardDirectRestricted Stock Units
25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 11, 2026 |  AGMB AgomAb Therapeutics NV | Award Stock Option (Right to Buy) | 56,328 | - | - | Direct |
| May 29, 2026 |  CRSP CRISPR Therapeutics AG | Award Restricted Stock Units | 22,000 | - | - | Direct |
| May 29, 2026 | CRSP CRISPR Therapeutics AG | Sale | 3,786 | $55.62 | $210,577 | Direct |
| May 28, 2026 | CRSP CRISPR Therapeutics AG | Exercise | 10,000 | - | $0 | Direct |
| Mar 20, 2026 | CRSP CRISPR Therapeutics AG | Award Stock Option (Right to Buy) | 38,499 | - | - | Direct |
| Mar 20, 2026 | CRSP CRISPR Therapeutics AG | Award Restricted Stock Units | 30,000 | - | - | Direct |
| Mar 16, 2026 | CRSP CRISPR Therapeutics AG | Sale | 3,150 | $48.26 | $152,019 | Direct |
| Mar 14, 2026 | CRSP CRISPR Therapeutics AG | Exercise | 8,125 | - | $0 | Direct |
| Oct 3, 2025 | CRSP CRISPR Therapeutics AG | Award Stock Option (Right to Buy) | 16,500 | - | - | Direct |
| May 30, 2025 | CRSP CRISPR Therapeutics AG | Award Restricted Stock Units | 25,000 | - | - | Direct |
1-10 of 16 transactions